LEON Team at the 4th LNP Formulation & Process Development Summit – Meet Us in Boston!
We’re excited to announce that the LEON team will be attending the 4th LNP Formulation & Process Development Summit in Boston from April 14–16, 2025.
Visit us at stand 10 and learn more about our Innovative FR-JET® Technology and our advanced products!
- Live Demonstration of NANOlab® – See our technology in action
- Expert Presentation – Our Senior Scientist Dr. Blerina Shkodra, will present: “A Holistic Approach for Reliable GMP Manufacturing of Nanoparticle Formulations at All Scales”
- Discover Collaboration Opportunities – Let’s shape the future of LNP manufactturing together
Schedule a meeting – Contact us in advance to set up a meeting and discuss how we can collaborate.
About LEON
leon-nanodrugs GmbH is a Munich-based pharmatech company specializing in the development of devices for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). LEON builds its innovative solutions based on its proprietary FR-JET® Technology. Its portfolio of devices, NANOscreen® for simplified formulation screening, NANOlab® for process development, and NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production.
LEON’s platform is aimed at enabling pharma companies, small biotech, research institutes, as well as CDMOs, to take full advantage of the significant progress being made in advanced therapies.
For general information and enquiries please email info@leon-nanodrugs.com